Skip to main content
67°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Halberd Corporation
< Previous
1
2
Next >
Halberd Corp. Launches "Halberd Cancer Therapeutics, LTD" Wholly Owned Subsidiary
July 20, 2022
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
HALB
Halberd's Antibody Effective Against all 4 SARS-CoV-2 Mutations, Including Omicron
July 14, 2022
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
HALB
Halberd Corporation Update, CEO Letter and 2022 Expectations
July 12, 2022
From
Halberd Corporation
Via
AccessWire
Tickers
HALB
Halberd Creates Subsidiary to Apply Its Patented Technology to Treat Cancer
June 21, 2022
From
Halberd Corporation
Via
AccessWire
Tickers
HALB
Halberd Corp. & Mississippi State University Discuss Animal Testing as Prelude to FDA Certification
June 08, 2022
From
Halberd Corporation
Via
AccessWire
Topics
Animal Testing
Exposures
Animal Testing
Product Safety
Tickers
HALB
Halberd Successfully Eliminates Excess Levels of Inflammatory Cytokines
May 24, 2022
From
Halberd Corporation
Via
AccessWire
Topics
Animal Testing
Exposures
Animal Testing
Product Safety
Tickers
HALB
Halberd Engages Professional Firm to Proceed with FDA Filings
May 18, 2022
From
Halberd Corporation
Via
AccessWire
Exposures
Product Safety
Tickers
HALB
Halberd Submits Audited Financials; Files Form-10 as First Step to Up-list to OTCQB
May 12, 2022
From
Halberd Corporation
Via
AccessWire
Topics
Animal Testing
Regulatory Compliance
Exposures
Animal Testing
Legal
Product Safety
Tickers
HALB
Dr. Gregg Sturrus' TEDx Talk(R) Features Halberd's Extracorporeal Treatment of Neurodegenerative Diseases
April 29, 2022
From
Halberd Corporation
Via
AccessWire
Tickers
HALB
Halberd CEO Letter
April 25, 2022
From
Halberd Corporation
Via
AccessWire
Tickers
HALB
Halberd Eliminates E. Coli in 20 Minutes vs. 7-10 Days with Conventional Antibiotics
April 18, 2022
From
Halberd Corporation
Via
AccessWire
Topics
Animal Testing
Exposures
Animal Testing
Tickers
HALB
Halberd Entering the Medical Metaverse(TM)
April 11, 2022
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
HALB
Halberd Continues In-Vitro Successes With Elimination of Protein Linked to Depression
April 04, 2022
From
Halberd Corporation
Via
AccessWire
Tickers
HALB
Infectious Disease Specialist Will Guide Halberd's Extracorporeal Elimination of Disease Antigens in Animals and Then Humans
March 16, 2022
From
Halberd Corporation
Via
AccessWire
Tickers
HALB
Halberd Expands Its Technical Expertise with the Addition of Microbiology Professor
March 08, 2022
From
Halberd Corporation
Via
AccessWire
Tickers
HALB
Halberd's COVID-19 Antibody is the Only One In Competitive Tests to Bind to Omicron Variant
March 01, 2022
From
Halberd Corporation
Via
AccessWire
Exposures
COVID-19
Product Safety
Tickers
HALB
Halberd Medical Breakthrough for the Treatment of Neurodegenerative Diseases Affecting 36 Million Americans Annually
February 22, 2022
From
Halberd Corporation
Via
AccessWire
Tickers
HALB
Halberd Eliminates 100% of Tau Protein From CSF - The 9th of 10 Target Neurodegenerative Disease Antigens
February 08, 2022
From
Halberd Corporation
Via
AccessWire
Tickers
HALB
Halberd Achieves Landmark Selective Elimination of Tau From an Antigen Mixture
February 01, 2022
From
Halberd Corporation
Via
AccessWire
Tickers
HALB
Halberd CEO Letter: 2021 Year-End & 2022 Outlook
January 25, 2022
From
Halberd Corporation
Via
AccessWire
Tickers
HALB
Halberd, Inc. (HALB) Reports Elimination of Target Antigens, Progressing to Treatments for Neurodegenerative Diseases
January 13, 2022
From
Halberd Corporation
Via
AccessWire
Tickers
HALB
Halberd Corporation Now an Official US Government Contractor
January 05, 2022
From
Halberd Corporation
Via
AccessWire
Tickers
HALB
Halberd Moves Closer to Proving Its Patented Technologies Eliminate Contributors to Neurodegenerative Diseases
December 20, 2021
From
Halberd Corporation
Via
AccessWire
Tickers
HALB
Halberd Eradicates Another Inflammatory Cytokine, Interleukin-12, In Its Continuing Effort To Eliminate Neurodegenerative Diseases
December 15, 2021
From
Halberd Corporation
Via
AccessWire
Tickers
HALB
Halberd Successfully Eradicates Interleukin-1 in Its Continued Progress Toward Eliminating Neurodegenerative Diseases
December 13, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Follow-up Verification Tests Prove 100% Eradication of TNF-alpha, a Major Contributing Factor to Alzheimer's Disease and PTSD/CTE
December 06, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
HALB
Halberd Successfully Eradicates TNF-a, a Major Contributing Factor to Alzheimer’s Disease
November 22, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Files Additional Extracorporeal Patent Application: Treatment of Covid-19 By Exposure to Tuned Radio Frequency Waves
November 08, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Successfully Eradicates IL-6, a Critical Factor in PTSD, CTE & Alzheimer’s Disease
November 01, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Files Provisional Patent on Breakthrough Obesity Treatment
October 25, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.